Weight-loss jab could be made for $3 a month, study finds
Cheap semaglutide, the drug in Ozempic and Wegovy, could help millions with diabetes and obesity in 160 countriesWeight-loss jabs such as Wegovy and Ozempic could be made for just $3 a month, according to new analysis, potentially making the treatment available to millions in poorer countries as patents expire.More than a billion people live with obesity worldwide, with rates rising fast in lower-income nations as they shift to westernised diets and more sedentary lifestyles. Continue reading...
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.